Valneva submits label extension application for Ixchiq with UK MHRA to expand its use to adolescents aged 12 to 17 years ...
Valneva SE, a specialty vaccine company, announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) to potentially expand the use of its chikungunya vaccine, …